4D
Live / Registered — Registered (as of 02 Jan 2024)
What this means for you
Registered since 02 Jan 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jan 2030: the §8 declaration of use).
Record
- Serial number
- 97693556
- Registration number
- 7259704
- Mark type
- Word mark
- Filed
- 28 Nov 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 02 Jan 2024
- Next maintenance filing
- §8 declaration of use, due by 02 Jan 2030 (grace period to 02 Jul 2030)
- Attorney of record
- Adam K Sacharoff
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals; Scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Pharmaceutical products design and development for medical and scientific use, and medical treatment; Pharmaceutical drug design and development featuring biomolecules
Owner
- 4D MOLECULAR THERAPEUTICS INC., Emeryville, CA, US
- 4D MOLECULAR THERAPEUTICS INC., Emeryville, CA, US
- 4D MOLECULAR THERAPEUTICS INC., Emeryville, CA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 02 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Sept 2023 — ASSIGNED TO EXAMINER
- 20 Dec 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Dec 2022 — NEW APPLICATION ENTERED